首页|异烟肼联合地塞米松胸腔内注射治疗结核性胸膜炎的效果

异烟肼联合地塞米松胸腔内注射治疗结核性胸膜炎的效果

扫码查看
目的 探讨异烟肼辅助地塞米松胸腔内注射治疗结核性胸膜炎(TP)的效果.方法 选择2018年12月—2023年2月贵州省黔南州人民医院收治的80例TP患者为研究对象,按随机数字表法将其分为对照组与观察组,各40例.对照组采用异烟肼治疗,观察组采用异烟肼联合地塞米松治疗.比较两组临床疗效、胸腔积液消失时间、胸膜厚度、肺功能及不良反应发生率.结果 观察组治疗总有效率为95.00%,高于对照组的80.00%,差异有统计学意义(P<0.05).观察组胸腔积液消失时间为(12.98±2.12)d,短于对照组,胸膜厚度为(1.43±0.35)mm,薄于对照组,组间差异有统计学意义(P<0.05).治疗 4 周后,观察组用力肺活量(FVC)为(3.75±0.42)L,第1秒用力呼气容积(FEV1)为(2.73±0.24)L,呼气流量峰值为(2.67±0.43)L/s,FEV1/FVC为(72.80±7.94)%,均高于对照组,组间差异有统计学意义(P<0.05).两组不良反应发生率比较,差异无统计学意义(P>0.05).结论 对TP患者使用异烟肼联合地塞米松胸腔内注射治疗效果更佳,可有效改善患者临床症状,缩短患者胸腔积液消失时间,改善患者肺功能.
The Therapeutic Effect of Isoniazid Combined with Dexamethasone Intrapleural Injection in the Treatment of Tuberculous Pleurisy
Objective To investigate the effect of intrathoracic injection of isoniazid and dexamethasone in the treatment of tuberculous pleurisy(TP).Methods 80 TP patients admitted to Qiannan People's Hospital of Guizhou Province from December 2018 to February 2023 were selected as the research objects.According to the random number table method,they were divided into a control group and an observation group,with 40 cases in each group.The control group was treated with isoniazid,and the observation group was treated with isoniazid combined with dexamethasone.The clinical efficacy,pleural effusion disappearance time,pleural thickness,lung function and adverse reactions were compared between the two groups.Results The clinical efficacy of the observation group was 95.00%,which was higher than 80.00%of the control group,and the difference was statistically significant(P<0.05).The disappearance time of pleural effusion in the observation group was(12.98±2.12)d,which was shorter than that in the control group,and the pleural thickness was(1.43±0.35)mm,which was thinner than that in the control group,the differences between the two groups were statistically significant(P<0.05).After 4 weeks of treatment,the forced vital capacity(FVC)of the observation group was(3.75±0.42)L,forced expiratory volume in the first second(FEV1)was(2.73±0.24)L,peak expiratory flow was(2.67±0.43)L/s,FEV1/FVC was(72.80±7.94)%,which were higher than those of the control group,the differences between the two groups were statistically significant(P<0.05).There was no significant difference in adverse reactions between the two groups(P>0.05).Conclusion Isoniazid combined with dexamethasone intrapleural injection is more effective in the treatment of TP patients,which can effectively improve the clinical symptoms of patients,shorten the disappearance time of pleural effusion,and improve the lung function of patients.

Tuberculous pleurisyIsoniazidDexamethasoneIntrathoracic injectionClinical effectLung function

陈小锰

展开 >

贵州省黔南州人民医院感染科,贵州黔南 558000

结核性胸膜炎 异烟肼 地塞米松 胸腔内注射 临床疗效 肺功能

2024

反射疗法与康复医学

反射疗法与康复医学

ISSN:
年,卷(期):2024.5(3)
  • 11